Abstract
Cardiovascular disease (CVD) is the leading cause of death in women of all age. An understanding of CVD in women is critical, especially given the aging population and the growing incidence of obesity, diabetes, and metabolic syndrome in our society. This chapter covers gender differences in risk factors for CVD, symptom presentation, and disease progression, as well as implications for diagnosis and treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Centers for Disease Control and Prevention. State-specific mortality from sudden cardiac death – United States. Centers for Disease Control and Prevention Web site. 1999. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5106a3.html. Published Feb. 15, 2002. Accessed 19 July 2010.
Jenkins JS, Flaker GC, Nolte B, et al. Causes of higher in-hospital mortality in women than in men after acute myocardial infarction. Am J Cardiol. 1994;73(5):319–22.
Gregg EW, Gu Q, Cheng YJ, Narayan KM, Cowie CC. Mortality trends in men and women with diabetes. Ann Intern Med. 2007;147:149–55.
Mosca L, Grundy SM, Judelson D, et al. Guide to preventative cardiology for women. AHA/ACC scientific statement. Circulation. 1999;99:2480–4.
Mosca L, Appel L, Benjamin E, et al. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation. 2004;109:672–93.
Steering Committee of the Physicians’ Health Study Research Group. Final report on the aspirin component of the ongoing Physicians’ Health Study. N Engl J Med. 1989;321:129–35.
Ridker PM, Cook NR, LeeI M, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med. 2005;352:1293–304.
Kannel WB, Vokonas PS. Demographics of the prevalence, incidence and management of coronary heart disease in the elderly and in women. Ann Epidemiol. 1992;2(1):5–14.
Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76–9.
Shaw LJ, Sharaf BL, Johnson BD, et al. The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health–National Heart, Lung, and Blood Institue-Sponsored Women’s Ischemia Syndrome Evaluation (WISE). Circulation. 2006;114:894–904.
Alexander KP, Shaw LJ, Delong ER, et al. Value of exercise treadmill testing in women. J Am Coll Cardiol. 1998;32:1657.
Nguyen JT, Berger AB, Duval S, Luepker RV. Gender disparity in cardiac procedures and medication use for acute myocardial infarction. Am Heart J. 2008;155(5):862–8.
Shaw LJ, Shaw RE, Bairey Merz CN, et al. Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology – National Cardiovascular Data Registry. Circulation. 2008;117:1787–801.
Hochman JS, Tamis JE, Thompson TD, et al. For the global use of strategies to open occluded coronary arteries in acute coronary syndromes IIb investigators. Sex, clinical presentation, and outcome in patients with acute coronary syndromes. N Engl J Med. 1999;341:226–32.
Chugh SS, Uy-Evanado A, Teodorescu C, et al. Women have a lower prevalence of structural heart disease as a precursor to sudden cardiac arrest. J Am Coll Cardiol. 2009;54(22):2006–11.
BaireyMerz CN, Johnson BD, Sharaf BL, et al. Hypoestrogenemia of hypothalamic origin and coronary artery disease in women evaluated for suspected ischemia: a report from the NHLBI-sponsored WISE study. J Am Coll Cardiol. 2003;41:413–9.
Egan KM, Lawson JA, Fries S, et al. COX-2-derived prostacyclin confers atheroprotection on female mice. Science. 2004;306:1954–7.
Tannebaum C, Barrett-Connor E, Laughlin GA, Platt RW. A longitudinal study of dehydroepiandrosterone sulphate (DHEAS) change in older men and women: the Rancho Bernardo Study. Eur J Endocrinol. 2004;151:717–25.
Matthews KA, Crawford SL, Chae CU, et al. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? J Am Coll Cardiol. 2009;54:2366–73.
Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J. 1986;111:383–90.
Kemp Jr HG. Left ventricular function in patients with the anginal syndrome and normal coronary angiograms. Am J Cardiol. 1973;32:375–6.
Panting JR, Gatehouse PD, Grothues F, et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med. 2002;346:1948–53.
Wittstein IS, Thiemann DR, Lima JAC, et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med. 2005;352:539–48.
Wong ND, Pio J, Valencia R, et al. Distribution of C-reactive protein and its relation to risk factors and coronary heart disease risk estimation in the National Health and Nutrition Examination Survey (NHANES) III. Prev Cardiol. 2001;4:109–14.
Teragawa H, Fukuda Y, Matsuda K, et al. Relation between C-reactive protein and coronary microvascular endothelial function. Heart. 2004;90(7):750–4.
Reis SE, Holubkov R, Smith AJC, et al. Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE Study. Am Heart J. 2001;141(5):735–41.
Rossi R, Nuzzo A, Origliani G, Modena MG. Prognostic role of flow-mediated dilation and cardiac risk factors in post-menopausal women. J Am Coll Cardiol. 2008;51:997–1002.
Olson MB, Kelsey SF, Matthews K, et al. Symptoms, myocardial ischaemia, and quality of life in women: results from the NHLBI-sponsored WISE study. Eur Heart J. 2003;24:1506–14.
Johnson BD, Bairey Merz CN, Kelsey SF, et al. Persistent chest pain predicts cardiovascular events in women with and without obstructive coronary artery disease: results from the NHLBI-sponsored WISE study. Eur Heart J. 2006;27:1408–15.
Robinson JG, Wallace R, Limacher M, et al. Cardiovascular risk in women with non-specific chest pain (from the Women’s Health Initiative Hormone Trials). Am J Cardiol. 2008;102:693–9.
Gulati M, Cooper-DeHoff RM, McClure C, et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the National Institutes of Health – National Heart, Lung, and Blood Institute-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) study and the St. James Women Take Heart (WTH) project. Arch Intern Med. 2009;169:843–50.
American Heart Association Web site. 2010. http://www.americanheart.org/downloadable/heart/1236184538758WOMEN.pdf. Accessed 16 July 2010.
Marrugat J, Sala J, Masia R, et al. Mortality differences between men and women following first myocardial infarction. JAMA. 1998;280:1405–9.
Levin RI. The puzzle of aspirin and sex [editorial]. N Engl J Med. 2005;352:1366–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Tolins-Mejia, M. (2012). Cardiovascular Disease in Women. In: Vlodaver, Z., Wilson, R., Garry, D. (eds) Coronary Heart Disease. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-1475-9_28
Download citation
DOI: https://doi.org/10.1007/978-1-4614-1475-9_28
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4614-1474-2
Online ISBN: 978-1-4614-1475-9
eBook Packages: MedicineMedicine (R0)